{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T20:57:44Z","timestamp":1790888264798,"version":"4.1.0"},"reference-count":43,"publisher":"American Society for Microbiology","issue":"11","license":[{"start":{"date-parts":[[2019,10,22]],"date-time":"2019-10-22T00:00:00Z","timestamp":1571702400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"funder":[{"DOI":"10.13039\/100000090","name":"DOD | United States Army | MEDCOM | Congressionally Directed Medical Research Programs","doi-asserted-by":"publisher","award":["JPC2 DM140274"],"award-info":[{"award-number":["JPC2 DM140274"]}],"id":[{"id":"10.13039\/100000090","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2019,11]]},"abstract":"<jats:p>\n            Recurrent vulvovaginal candidiasis (RVVC) is a widespread chronic infection that has a substantial negative impact on work and quality of life. The development of antimicrobial resistance and biofilm formation are speculated to contribute to\n            <jats:italic>Candida<\/jats:italic>\n            pathogenicity and treatment ineffectiveness. Designed antimicrobial peptides (dAMPs) are chemically modified from endogenous antimicrobial peptides that provide the first line of defense against pathogens.\n          <\/jats:p>","DOI":"10.1128\/aac.02690-18","type":"journal-article","created":{"date-parts":[[2019,8,22]],"date-time":"2019-08-22T10:47:38Z","timestamp":1566470858000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":24,"title":["Designed Antimicrobial Peptides for Recurrent Vulvovaginal Candidiasis Treatment"],"prefix":"10.1128","volume":"63","author":[{"given":"Kathryn W.","family":"Woodburn","sequence":"first","affiliation":[{"name":"Riptide Bioscience, Inc., Vallejo, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Edward","family":"Clemens","sequence":"additional","affiliation":[{"name":"Riptide Bioscience, Inc., Vallejo, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesse","family":"Jaynes","sequence":"additional","affiliation":[{"name":"Integrative Biosciences, College of Agriculture, Environment and Nutrition Sciences, Tuskegee University, Tuskegee, Alabama, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lydia-Marie","family":"Joubert","sequence":"additional","affiliation":[{"name":"Microbiology Department, Stellenbosch University, Stellenbosch, South Africa"},{"name":"Central Analytical Facilities, Stellenbosch University, Stellenbosch, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfred","family":"Botha","sequence":"additional","affiliation":[{"name":"Microbiology Department, Stellenbosch University, Stellenbosch, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasan","family":"Nazik","sequence":"additional","affiliation":[{"name":"California Institute for Medical Research, San Jose, California, USA"},{"name":"Division of Infectious Diseases and Geographic Medicine, Stanford University, Stanford, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Stevens","sequence":"additional","affiliation":[{"name":"California Institute for Medical Research, San Jose, California, USA"},{"name":"Division of Infectious Diseases and Geographic Medicine, Stanford University, Stanford, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7525-11-169"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1067\/s0002-9378(03)00726-9"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2015.06.067"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01065-17"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(18)30103-8"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.micinf.2016.01.002"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1067\/mob.2001.111938"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1086\/596757"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa033114"},{"key":"e_1_3_2_11_2","first-page":"307","article-title":"Effectiveness of fluconazole for suppressive maintenance therapy in patients with RVVC: a randomized placebo-controlled study","volume":"8","author":"Bolouri F","year":"2009","unstructured":"Bolouri F, Moghadami Tabrizi N, Niroomand N, Azmoodeh A, Emami S, Falahati M. 2009. Effectiveness of fluconazole for suppressive maintenance therapy in patients with RVVC: a randomized placebo-controlled study. Iranian J Pharmaceutical Res 8:307\u2013313.","journal-title":"Iranian J Pharmaceutical Res"},{"key":"e_1_3_2_12_2","unstructured":"Food and Drug Administration. 2018. Drug safety communication FDA to review study examining use of oral fluconazole (diflucan) in pregnancy. Food and Drug Administration Washington DC. https:\/\/www.fda.gov\/downloads\/Drugs\/DrugSafety\/UCM497705.pdf."},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1136\/sti.79.3.249"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.4236\/aid.2013.34035"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/civ353"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1099\/jmm.0.46569-0"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1128\/EC.00050-15"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1038\/415389a"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.17-22243"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1358\/dof.2010.035.03.1452077"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1021\/acs.molpharmaceut.6b00654"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1080\/02713680590968637"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1139\/w98-032"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2017.04.002"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbpa.2017.03.014"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1080\/14712598.2017.1315402"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2016.09.018"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1002\/pro.3203"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1038\/srep27258"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1099\/mic.0.039354-0"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/civ358"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1004480"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00318-08"},{"key":"e_1_3_2_34_2","first-page":"243","article-title":"The use of antimicrobial peptides in ophthalmology: an experimental study in corneal preservation and the management of bacterial keratitis","volume":"100","author":"Mannis MJ","year":"2002","unstructured":"Mannis MJ. 2002. The use of antimicrobial peptides in ophthalmology: an experimental study in corneal preservation and the management of bacterial keratitis. Trans Am Ophthalmol Soc 100:243\u2013271.","journal-title":"Trans Am Ophthalmol Soc"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofw172.1339"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.4103\/0366-6999.181964"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)37448-9"},{"key":"e_1_3_2_38_2","volume-title":"CLSI M60","author":"Clinical and Laboratory Standards Institute","year":"2017","unstructured":"Clinical and Laboratory Standards Institute. 2017. Performance standards for antifungal susceptibility testing of yeasts; 1st informational supplement. CLSI M60. Clinical and Laboratory Standards Institute, Wayne, PA."},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1128\/aac.25.4.450"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1099\/mic.0.000539"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mimet.2016.11.002"},{"key":"e_1_3_2_42_2","unstructured":"Perkin Elmer. 2019. RediFect lentiviral particles transfection protocol. Perkin Elmer Waltham MA. https:\/\/www.perkinelmer.com\/lab-solutions\/resources\/docs\/SPC_RediFect_Lentiviral_Particles_Protocol_of_infection.pdf. Accessed 28 August 2019."},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00937-12"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2018.10.023"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.02690-18","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.02690-18","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T21:23:27Z","timestamp":1645478607000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.02690-18"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":43,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["10.1128\/AAC.02690-18"],"URL":"https:\/\/doi.org\/10.1128\/aac.02690-18","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"2019-01-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-08-10","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-10-22","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e02690-18"}}